908 Devices to Report Second Quarter Financial Results on August 4, 2021
908 Devices Inc. (Nasdaq: MASS) announced it will release its financial results for Q2 2021 on August 4, 2021, before market open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
908 Devices Inc. (Nasdaq: MASS) announced it will release its financial results for Q2 2021 on August 4, 2021, before market open. A conference call will follow at 5:30 a.m. PT / 8:30 a.m. ET, available via live webcast on the company’s website. The session will be archived for replay within 24 hours. 908 Devices specializes in mass spectrometry devices that serve critical applications in life sciences and forensics, showcasing its commitment to making laboratory tools more accessible.
Positive
- Anticipation for Q2 2021 financial results could indicate growth or strong performance.
- Webcast allows investors to engage directly with management.
Negative
- None.
Details
News Market Reaction – MASS
The recorded move for MASS in the trading session of this news was +5.80%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, July 21, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2021 before market open on Wednesday, August 4, 2021. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.908devices.com. The webcast will be archived and available for replay within 24 hours after the event.
About 908 Devices
908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics, and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation, and machine learning.
Investor Contact
Carrie Mendivil
IR@908devices.com
Media Contact
Katie Johnston
PAN Communications for 908 Devices
908devices@pancomm.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.